Tags

Type your tag names separated by a space and hit enter

Prem Baby Triple P: a randomised controlled trial of enhanced parenting capacity to improve developmental outcomes in preterm infants.
BMC Pediatr. 2015 Mar 04; 15:15.BPed

Abstract

BACKGROUND

Very preterm birth (<32 weeks gestation) is associated with motor, cognitive, behavioural and educational problems in children and maternal depression and withdrawal. Early interventions that target parenting have the greatest potential to create sustained effects on child development and parental psychopathology. Triple P (Positive Parenting Program) has shown positive effects on child behaviour and adjustment, parenting practices and family functioning. Baby Triple P for Preterm infants, has been developed to target parents of very preterm infants. This study tests the effectiveness of Baby Triple P for Preterm infants in improving child and parent/couple outcomes at 24 months corrected age (CA).

METHODS/DESIGN

Families will be randomised to receive either Baby Triple P for Preterm infants or Care as Usual (CAU). Baby Triple P for Preterm infants involves 4 × 2 hr group sessions at the hospital plus 4 × 30 min telephone consultations soon after transfer (42 weeks C.A.). After discharge participants will be linked to community based Triple P and intervention maintenance up to 24 months C.A. Assessments will be: baseline, post-intervention (6 weeks C.A.), at 12 and 24 months C.A. The primary outcome measure is the Infant Toddler Social & Emotional Assessment (ITSEA) at 24 months C.A. Child behavioural and emotional problems will be coded using the mother-toddler version of the Family Observation Schedule at 24 months C.A. Secondary outcome will be the Bayley Scales of Infant and Toddler Development (BSID III) cognitive development, language and motor abilities. Proximal targets of parenting style, parental self-efficacy, parental mental health, parental adjustment, parent-infant attachment, couple relationship satisfaction and couple communication will also be assessed. Our sample size based on the ITSEA, has 80% power, predicted effect size of 0.33 and an 85% retention rate, requires 165 families are required in each group (total sample of 330 families).

DISCUSSION

This protocol presents the study design, methods and intervention to be analysed in a randomised trial of Baby Triple P for Preterm infants compared to Care as Usual (CAU) for families of very preterm infants. Publications of all outcomes will be published in peer reviewed journals according to CONSORT guidelines.

TRIAL REGISTRATION

Australian New Zealand Clinical Trials Registry: ACTRN12612000194864.

Authors+Show Affiliations

The University of Queensland Centre for Clinical Research, Faculty of Health Sciences, The University of Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia. p.colditz@uq.edu.au. Royal Brisbane and Women's Hospital, Brisbane, Australia. p.colditz@uq.edu.au.The Parenting and Family Support Centre, School of Psychology, Faculty of Social and Behavioural Sciences, The University of Queensland, Brisbane, Australia. matts@psy.uq.edu.au.Queensland Cerebral Palsy and Rehabilitation Research Centre, School of Medicine, Faculty of Health Sciences, The University of Queensland, Brisbane, Australia. r.boyd@uq.edu.au.The University of Queensland Centre for Clinical Research, Faculty of Health Sciences, The University of Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia. m.pritchard@uq.edu.au. Royal Brisbane and Women's Hospital, Brisbane, Australia. m.pritchard@uq.edu.au.Mater Mothers' Hospital, Brisbane, Australia. Peter.Gray@mater.org.au.Mater Mothers' Hospital, Brisbane, Australia. mocalla1@bigpond.net.au.Early Cognitive Development Centre, The School of Psychology, Faculty of Social and Behavioural Sciences, The University of Queensland, Brisbane, Australia. vps@psy.uq.edu.au.Queensland Cerebral Palsy and Rehabilitation Research Centre, School of Medicine, Faculty of Health Sciences, The University of Queensland, Brisbane, Australia. koawhittingham@uq.edu.au. The School of Psychology, The University of Queensland, Faculty of Social and Behavioural Sciences, The University of Queensland, Brisbane, Australia. koawhittingham@uq.edu.au.QIMR Berghofer Medical Research Institute, Brisbane, Australia. Peter.ORourke@qimr.edu.au.The University of Queensland Centre for Clinical Research, Faculty of Health Sciences, The University of Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia. l.winter@uq.edu.au. The Parenting and Family Support Centre, School of Psychology, Faculty of Social and Behavioural Sciences, The University of Queensland, Brisbane, Australia. l.winter@uq.edu.au.Royal Brisbane and Women's Hospital, Brisbane, Australia. t.evans3@uq.edu.au. The School of Psychology, The University of Queensland, Faculty of Social and Behavioural Sciences, The University of Queensland, Brisbane, Australia. t.evans3@uq.edu.au.Royal Brisbane and Women's Hospital, Brisbane, Australia. m.herd@uq.edu.au. The School of Psychology, The University of Queensland, Faculty of Social and Behavioural Sciences, The University of Queensland, Brisbane, Australia. m.herd@uq.edu.au.Royal Brisbane and Women's Hospital, Brisbane, Australia. j.ahern@psy.uq.edu.au. The School of Psychology, The University of Queensland, Faculty of Social and Behavioural Sciences, The University of Queensland, Brisbane, Australia. j.ahern@psy.uq.edu.au.Mater Mothers' Hospital, Brisbane, Australia. Luke.Jardine@mater.org.au. The School of Psychology, The University of Queensland, Faculty of Social and Behavioural Sciences, The University of Queensland, Brisbane, Australia. Luke.Jardine@mater.org.au.

Pub Type(s)

Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

25884634

Citation

Colditz, Paul, et al. "Prem Baby Triple P: a Randomised Controlled Trial of Enhanced Parenting Capacity to Improve Developmental Outcomes in Preterm Infants." BMC Pediatrics, vol. 15, 2015, p. 15.
Colditz P, Sanders MR, Boyd R, et al. Prem Baby Triple P: a randomised controlled trial of enhanced parenting capacity to improve developmental outcomes in preterm infants. BMC Pediatr. 2015;15:15.
Colditz, P., Sanders, M. R., Boyd, R., Pritchard, M., Gray, P., O'Callaghan, M. J., Slaughter, V., Whittingham, K., O'Rourke, P., Winter, L., Evans, T., Herd, M., Ahern, J., & Jardine, L. (2015). Prem Baby Triple P: a randomised controlled trial of enhanced parenting capacity to improve developmental outcomes in preterm infants. BMC Pediatrics, 15, 15. https://doi.org/10.1186/s12887-015-0331-x
Colditz P, et al. Prem Baby Triple P: a Randomised Controlled Trial of Enhanced Parenting Capacity to Improve Developmental Outcomes in Preterm Infants. BMC Pediatr. 2015 Mar 4;15:15. PubMed PMID: 25884634.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prem Baby Triple P: a randomised controlled trial of enhanced parenting capacity to improve developmental outcomes in preterm infants. AU - Colditz,Paul, AU - Sanders,Matthew R, AU - Boyd,Roslyn, AU - Pritchard,Margo, AU - Gray,Peter, AU - O'Callaghan,Michael J, AU - Slaughter,Virginia, AU - Whittingham,Koa, AU - O'Rourke,Peter, AU - Winter,Leanne, AU - Evans,Tracey, AU - Herd,Michael, AU - Ahern,Jessica, AU - Jardine,Luke, Y1 - 2015/03/04/ PY - 2014/10/30/received PY - 2015/02/04/accepted PY - 2015/4/18/entrez PY - 2015/4/18/pubmed PY - 2016/1/5/medline SP - 15 EP - 15 JF - BMC pediatrics JO - BMC Pediatr VL - 15 N2 - BACKGROUND: Very preterm birth (<32 weeks gestation) is associated with motor, cognitive, behavioural and educational problems in children and maternal depression and withdrawal. Early interventions that target parenting have the greatest potential to create sustained effects on child development and parental psychopathology. Triple P (Positive Parenting Program) has shown positive effects on child behaviour and adjustment, parenting practices and family functioning. Baby Triple P for Preterm infants, has been developed to target parents of very preterm infants. This study tests the effectiveness of Baby Triple P for Preterm infants in improving child and parent/couple outcomes at 24 months corrected age (CA). METHODS/DESIGN: Families will be randomised to receive either Baby Triple P for Preterm infants or Care as Usual (CAU). Baby Triple P for Preterm infants involves 4 × 2 hr group sessions at the hospital plus 4 × 30 min telephone consultations soon after transfer (42 weeks C.A.). After discharge participants will be linked to community based Triple P and intervention maintenance up to 24 months C.A. Assessments will be: baseline, post-intervention (6 weeks C.A.), at 12 and 24 months C.A. The primary outcome measure is the Infant Toddler Social & Emotional Assessment (ITSEA) at 24 months C.A. Child behavioural and emotional problems will be coded using the mother-toddler version of the Family Observation Schedule at 24 months C.A. Secondary outcome will be the Bayley Scales of Infant and Toddler Development (BSID III) cognitive development, language and motor abilities. Proximal targets of parenting style, parental self-efficacy, parental mental health, parental adjustment, parent-infant attachment, couple relationship satisfaction and couple communication will also be assessed. Our sample size based on the ITSEA, has 80% power, predicted effect size of 0.33 and an 85% retention rate, requires 165 families are required in each group (total sample of 330 families). DISCUSSION: This protocol presents the study design, methods and intervention to be analysed in a randomised trial of Baby Triple P for Preterm infants compared to Care as Usual (CAU) for families of very preterm infants. Publications of all outcomes will be published in peer reviewed journals according to CONSORT guidelines. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry: ACTRN12612000194864. SN - 1471-2431 UR - https://www.unboundmedicine.com/medline/citation/25884634/Prem_Baby_Triple_P:_a_randomised_controlled_trial_of_enhanced_parenting_capacity_to_improve_developmental_outcomes_in_preterm_infants_ L2 - https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-015-0331-x DB - PRIME DP - Unbound Medicine ER -